The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

For decades, taking a daily low-dose aspirin was a widely accepted practice for preventing heart attacks and strokes. But a series of clinical trials have led to a major shift in medical guidance — ...

The global aspirin drug market is poised for substantial growth over the next decade, with its value expected to increase ...

Is daily aspirin really necessary for heart disease prevention? Find out the truth behind the changing recommendations.

A randomized study has produced some hopeful news for colorectal cancer survivors with an unlikely suspect: the commonly used ...

Statins, a class of cholesterol-lowering drugs, have no effect on kidney function, a research team led by the University of ...

Decrease in use seen among older adults, adults with low ASCVD risk, but also among those with higher ASCVD risk ...

Adjuvant treatment with aspirin is associated with a lower risk of recurrence at 3 years in CRC patients with PI3K pathway ...

After guideline changes, aspirin use dropped off overall, even for higher-risk patients in whom it might still be considered.